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ABSTRACT  
NG2 cells robustly proliferate during the first week after spinal cord injury (SCI), a portion of 
which give rise to new oligodendrocytes (OLs) capable of remyelination. Our prior work showed 
spontaneous NG2 cell proliferation for 4 weeks post-injury (wpi); whether these later responding 
cells still generate OLs and remyelinate axons in the chronic injury environment, however, is 
unknown. Here we used two PDGFαR-reporter mouse lines and rats injected with a GFP-
retrovirus to assess NG2 cell fate through 80dpi. Notably, mature OLs were generated from 
NG2/PDGFαR cells as late as 8-12wpi. GFP+ processes of new OL lineage cells ensheathed 
axons at all times examined, some of which co-localized with MBP or abutted Caspr+ profiles, 
suggesting functional myelination. Astrocytes in chronic tissue expressed the pro-OL 
differentiation and survival factors CNTF and FGF-2, and also expressed pSTAT3 through 
12wpi revealing active signaling of the JAK/STAT pathway, which is induced by CNTF and 
related factors. Finally, genes associated with NG2 cell fate determination, such as Hes5, ID2, 
and ID4, were significantly altered late after injury. Collectively, these data indicate that 
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endogenous repair processes such as oligodendrogenesis, axon ensheathment and remyelination 
continue chronically after SCI, revealing that the injured spinal cord remains in a very dynamic 
state for 2-3 months post-injury. This previously unappreciated spontaneous reparative process 
may potentially be leveraged therapeutically to further enhance repair, and should be a 
consideration when testing agents that may inadvertently disrupt it. 
   
INTRODUCTION  
NG2 cells, also known as oligodendrocyte progenitors, give rise to myelinating oligodendrocytes 
(OLs) during development and in adulthood (Nishiyama et al., 2009). These cells are 
traditionally identified by NG2 and platelet-derived growth factor alpha receptor (PDGFαR) 
expression (Nishiyama et al., 1996; Richardson et al., 2011) and are the most proliferative cells 
of adult CNS (Horner et al., 2002; Dawson et al., 2003).  
NG2 cells retain their role as progenitors after injury or demyelination (Watanabe et al., 2002; 
Keirstead et al., 2005; Lytle et al., 2009; Tripathi et al., 2010). This is well demonstrated in the 
context of spinal cord injury (SCI), which causes extensive cell death and significant cell 
proliferation (McTigue et al., 2001; Zai and Wrathall, 2005; Horky et al., 2006; Barnabé-Heider 
et al., 2010; Almad et al., 2011). OLs are lost in the first hours after SCI (Zai and Wrathall, 
2005), and protracted OL apoptosis continues for 2-3 weeks post-injury (wpi), especially distal 
to the lesion (Crowe et al., 1997; Grossman et al., 2001). Surviving OLs are post-mitotic and 
cannot remyelinate axons (Keirstead and Blakemore, 1997). Thus, surviving NG2 cells are the 
major source for OL replacement and remyelination after SCI. Previous work demonstrated 
significant NG2 cell proliferation during the first 4 weeks after SCI (McTigue et al., 2001; Horky 
et al., 2006; Lytle et al., 2006; Rabchevsky et al., 2007). Over the first 2wpi, a portion of these 
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dividing NG2 cells differentiates into OLs, particularly along lesion borders (Zai & Wrathall, 
2005; Horky et al., 2006; Tripathi and McTigue, 2007; Lytle & Wrathall, 2007). These new OLs 
likely contribute to remyelination as several classic studies have shown evidence of OL 
remyelination beginning around 3wpi (Gledhill et al., 1973; Harisson et al., 1975). More recent 
work also demonstrated OL remyelination 14 days after SCI (Sellers et al., 2009).   
  
While acute NG2 cell responses after SCI are well documented, there is a substantial gap in the 
literature regarding NG2 cell behavior chronically. It is unknown if new OLs are generated 
beyond 2wpi and, if so, if they remyelinate axons. Therefore, we tested the hypothesis that 
protracted NG2 cell proliferation results in chronic oligodendrogenesis after SCI. As lesions 
evolve differently between rodent models, two different PDGFαR-reporter mice lines and adult 
rats injected with a GFP-expressing retrovirus were used to track NG2 cell fate for 12wpi. Gene 
changes associated with NG2 cell fate were also examined. Results reveal that 
oligodendrogenesis occurs continuously for at least 8-12 wpi after spinal contusion, along with 
signs of functional remyelination by late-born OLs. Astrocytes in the chronic lesion environment 
express pro-survival growth factors for OLs and NG2 cells, and NG2 cell fate genes display 
dynamic changes for several weeks post-injury. Collectively these data highlight that 
endogenous cell replacement continues for at least 3 months after SCI and that the chronic lesion 
milieu remains in a dynamic state. This long-term endogenous repair should be considered when 
designing drug treatments or cell transplantation strategies that may either take advantage of or 
inadvertently disrupt this chronic spontaneous repair. 
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METHODS: 
Spinal cord injury 
All surgical and postoperative care procedures were performed in accordance with The Ohio 
State University Institutional Animal Care and Use Committee. Adult male and female mice 
(~12 weeks old) and adult female Sprague-Dawley rats (~250g) were anesthetized with a 
ketamine/xylazine cocktail (10mg/kg, 80mg/kg, respectively) and the spinal cord exposed at the 
T9 (mouse) or T8 (rat) vertebral level via a single-level laminectomy. The animals then received 
either a moderate-severe (75 kDyne force; mouse) or moderate (150 kDyne force; rat) spinal 
contusion injury using the Infinite Horizons device (Precision Instruments). A subset of rats 
received a comparable moderate injury with the Ohio State University electromechanic spinal 
cord injury device (0.9mm displacement). The muscles overlying the spinal cord were then 
sutured and the skin was closed using surgical clips. Animals were given 2cc (mouse) or 5cc 
(rat) of saline and placed in warm recovery cages. Post-surgical care included 5 days treatment 
with antibiotics (Gentomicin, 5 mg/kg) and saline to maintain hydration, and twice-a-day manual 
bladder expression until spontaneous voiding returned. Sham animals received a laminectomy as 
described above but did not receive spinal cord injuries. All animals were assessed prior to injury 
for normal walking (score of 21 on BBB scale).  
Retrovirus production and injection 
A gammaretrovirus based on the murine leukemia virus (MLV) was used to transfect dividing 
cells. Retroviral encoding the green fluorescence protein (RV-GFP, Addgene # 16664) was 
produced by calcium chloride transient transfection into HEK293 cells, followed by supernatant 
viral purification by ultracentrifugation (Tashiro et al., 2006). Determination of viral titer was 
performed by serial dilution and visualization of colonies expressing GFP. The viral titer 
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obtained ranged from 0.5 to 1x109 infections units per ml. The virus was aliquoted and stored in 
-80 °C until used.  
 
For intraspinal injections, rats were anesthetized as above on day 1, 2, 7, 14, 21, or 28 post-injury 
and the laminectomy site was re-exposed (see Table 2 for group details). A volume of 1µl of 
GFP-retrovirus solution was carefully drawn up into a sterile Hamilton syringe, which was 
gently inserted into the center of the lesion site. The solution was slowly injected into the spinal 
cord and the syringe maintained in place for an additional two minutes to prevent back-flux from 
the injection site. The surgery site was closed as above and animals returned to their home cages. 
Sham animals (n=4) that had received a laminectomy but no injury were similarly injected with 
the 1µl of GFP-retrovirus solution and sacrificed three weeks later.  
 
Generation of PDGFαR-CreER:mT/mG transgenic mice  
Since NG2 is expressed by pericytes and some macrophages after SCI, PDGFαR reporter mice 
were used for this study. PDGFαR-CreER transgenic mice have previously been described (for 
detailed information, see Supplementary information in Rivers et al., 2008). Heterozygous 
PDGFαR-CreER mice that were backcrossed with C57BL/6J mice for four generations were 
bred with mT/mG mice (Jackson Laboratories, strain B6.129(Cg)-Gt(ROSA)26Sortm4(ACTB-
tdTomato,-EGFP)Luo/J) in which all cells ubiquitously express membrane-targeted tandem dimer 
Tomato (mT) prior to Cre-mediated recombination (Muzumdar et al., 2007) (Fig 4A). All mice 
used for experiments were PdgfαR+ and heterozygous for mT/mG. After recombination, cells 
transcribing the PDGFαR promoter express membrane-targeted enhanced GFP (mG). 
Recombination was induced by oral administration of tamoxifen (300mg/kg) for four 
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consecutive days starting at 1, 14, 21, 28, or 42dpi and animals were sacrificed three weeks later 
(see Table 2 for group details).  
 
Generation of PDGFαR-ROSA transgenic mice 
Heterozygous PDGFαR-CreER transgenic mice were also similarly crossed with ROSA26-EYFP 
mice (Jackson Laboratories, strain B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J) to generate 
PDGFαR-ROSA mice that express cytoplasmic GFP under the control of the PDGFαR promoter 
after recombination. Recombination was induced by oral administration of tamoxifen 
(200mg/kg) for four consecutive days starting at 28 or 52dpi, and animals were sacrificed at 52 
and 80dpi (~7 and 12wpi), respectively (see Table 2 for group details).   
 
Tissue processing: Immunohistochemistry 
For tissue collection, rats were deeply anesthetized with ketamine and xylazine (1.5X surgery 
dose above), and then perfused transcardially with PBS followed by 250ml of 4% 
paraformaldehyde in PBS. Spinal cords were removed, post-fixed for 2h at 4°C, and placed in 
0.2M PB overnight. Tissue was cryoprotected in 30% sucrose at 4°C for 48h. For tissue 
embedding, spinal cords were frozen on dry ice and cut into 4mm blocks centered on the 
injection site. After submersion in OCT compound (Electron Microscopy Sciences), blocks were 
frozen, and cross sections were cut at 10µm on a cryostat and mounted onto slides. Tissue was 
stored at -20°C until used.  
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Immunohistochemistry  
Sections were then rinsed in 0.1M PBS and blocked for nonspecific antigen binding using 4% 
BSA/0.1% Triton-100/PBS (BP+) for 1h. Next, sections were incubated in primary antibody 
overnight at 4°C. Sections were rinsed and treated with horse biotinylated antiserum (horse anti-
mouse IgG 1:800 in BP+; Vector Laboratories) for 1h at room temperature. After rinsing, 
endogenous peroxidase activity was quenched using a 4:1 solution of methanol/30% hydrogen 
peroxide for 15 min in the dark. Sections were then treated with Elite avidin–biotin enzyme 
complex (ABC; Vector Laboratories) for 1h. Visualization of labeling was achieved using DAB 
or SG substrates (Vector Laboratories). Sections were rinsed, dehydrated, and coverslipped with 
Permount (Fisher Scientific). Sections were labeled with NG2 and Ki-67 to stain for 
oligodendrocyte progenitor cells and proliferating cells, respectively. For a complete list of 
antibodies used, see Table 1. 
 
Immunofluorescence 
Sections were rinsed in 0.1M PBS and blocked for nonspecific antigen binding using BP+ or 4% 
BSA/0.3% Triton-100/PBS (BP3+) for 1h. Next, sections were incubated in primary antibody 
overnight at 4°C. Sections were rinsed and incubated with an AlexaFluor secondary antibody 
(1:500; Invitrogen) for 1h. For double- and triple-label immunofluorescence, sections were 
blocked and treated with primary and secondary antibodies, as above. After rinses, slides were 
coverslipped with Immu-Mount (Thermo Scientific). In cases where the primary antibody was 
raised in the same species as the tissue being labeled (mouse anti-CC1), the primary and 
secondary antibodies were first complexed together in 4%BSA/PBS/0.1andTx-100/0.3%NGS at 
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37°C for one hour, followed by the addition of normal mouse serum (1:500 dilution) for another 
hour, and then left on ice for 2 more hours.  
 
Microscopy and quantitative analysis: 
Immunofluorescent labeling was analyzed by confocal microscopy (Olympus FV1000 laser 
scanning confocal microscope) and Fluoview software. For quantification of fluorescent 
GFP+/CC1+ cells, nine non-overlapping images per spinal cord section (eight around the 
perimeter and one focused on the central canal) were collected at the epicenter, 0.15mm, and 
0.45mm rostral and caudal to the injury site. The total number of GFP+/CC1+ cells from all nine 
images per section were summed and expressed as a fraction over the total area (µm3) of spinal 
cord represented in the same images. A cell was counted if the CC1 label co-localized with 
DAPI and was completely surrounded by GFP labeling. A 2-way non-repeated measures 
ANOVA was used to analyze CC1/GFP+ cell counts with a Bonferroni post-hoc test, and 
significance was reported when p<0.05.  
 
A Zeiss Axioskop 2 Plus microscope with a Sony 970 three-chip color camera was used to 
analyze non-fluorescent sections. Cells double-labeled for NG2 and Ki-67 were manually 
counted at high power (40X) throughout entire spinal cord cross sections. Cell counting was 
conducted in a conservative manner, and all cell counts are expressed as cells per mm2. Criteria 
for a proliferating NG2 cell to be counted included a clearly defined border immunoreactive for 
NG2 surrounding an entire nucleus immunoreactive for Ki-67. These criteria had to be met in the 
same plane of focus. Care was taken to avoid counting NG2+ pericytes or macrophages, which 
are both easily distinguished by cellular morphology. A 1-way ANOVA was used to analyze 
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NG2/Ki-67+ cells counts where significance was reported when p<0.05.  
Quantitative real-time PCR 
cDNA was prepared from RNA isolated from mouse SCI tissue centered around the injury site as 
previously described using the Trizol method (Kigerl et al., 2007). Samples were collected at 
1dpi, 3dpi, 1wpi, 2wpi, and 4wpi as well as from naïve tissue (n=4, 5, 5, 4, 5, 5, respectively). 
Levels of PCR product were measured using SYBR Green ﬂuorescence. The primer sequences 
used were as follows: 18S(F) TTCGGAACTGAGGCCATGAT, (R) 
TTTCGCTCTGGTCCGTCTTG; Id2(F) GCTCTACAACATGAACGACTGCTACT, (R) 
TGCAGGTCCAAGATGTAATCGA; ID4(F) GAGACTCACCCTGCTTTGCT, (R) 
AGAATGCTGTCACCCTGCTT; Hes5(F) GCTGAGTGCTTTCCTATGAGGAA, (R) 
GCCCTGGGCACATTTGC; BMP2(F) CGTGCGCAGCTTCCATCACG, (R) 
GAAGAAGCGCCGGGCCGTTT; BMP4 (F) GCATCCGAGCTGAGAGACCCCA, (R) 
ATCCCATCAGGGACGGAGACCA. Data were analyzed using the Ct method (Livak & 
Schmittgen, 2001) and a one-way ANOVA with a Tukey post-hoc test. Significance was 
reported when p<0.05.   
   
RESULTS 
NG2 cells proliferate for 4 weeks after SCI, are maintained for at least 3 subsequent weeks 
and are located throughout the injured rat spinal cord  
While several studies have shown that acutely dividing NG2 cells give rise to new OLs early 
after SCI, the long-term response and distribution of new NG2 cells is not known. To follow the 
fate of dividing NG2 cells after rat SCI, a one-time injection of a GFP-expressing retrovirus into 
the lesion was performed at different times post-injury and the rats allowed to survive an 
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additional 1 – 4 weeks (Table 2). This resulted in GFP expression by cells dividing at the time of 
virus injection, which allowed the fate of those cells to be followed over time.   
  
To confirm that proliferating cells labeled by the GFP retrovirus could still be visualized 3-4 
weeks later, virus was injected into the lesion at 1d or 2dpi and spinal cords examined at 28dpi. 
In this tissue, robust GFP labeling was present in cells throughout ~1cm of tissue centered on the 
injury epicenter (Fig 1A). GFP cells were present within the lesion cavity and in spared white 
and gray matter surrounding the injury site. To assure that the large number of GFP+ cells was 
not an artifact of the virus injection itself, GFP-retrovirus was injected into naïve rat spinal cords 
(n=4) and the tissue examined 3 weeks later. In contrast to the SCI tissue where GFP+ cells were 
present throughout ~1cm of tissue (Fig 1A), GFP expression in naïve tissue was minimal and 
confined to ± 0.5mm around the injection site (Fig 1B), indicating that the injection stimulated 
only minor local proliferation.    
  
The next step was to determine if proliferating NG2 cells would be labeled 1-4 weeks after virus 
injection. Thus, virus was injected at 1 or 2dpi (a time of robust NG2 cell proliferation) and 
spinal cords examined at 1wpi and 4wpi for GFP+ NG2 cells. At 1wpi, GFP+ NG2 cells were 
detected in all spinal cords examined, indicating that GFP-labeled NG2 cells dividing at 24 or 
48h post-injury were maintained for 5-6 more days (Fig 1C).   
  
A large number of GFP+ NG2 cells labeled at 1dpi persisted for 4wpi and were mainly located 
along lesion borders and in spared gray and white matter up to 4mm distal to the injury epicenter 
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(Fig 1D E). Thus, a portion of NG2 cells proliferating at 1dpi at the lesion site are maintained for 
at least 4 weeks post-injury and distribute around and distal to the lesion.   
  
To determine the fate of NG2 cells dividing at different times post-injury, GFP-retrovirus was 
injected into the spinal cord lesion of rats at 1, 2, 3, or 4wpi. Animals from each cohort survived 
an additional 3 weeks (i.e., 4-7wpi) and spinal cords were examined for the presence and 
distribution of GFP+ NG2 cells (Table 2). At every time examined, GFP+ NG2 cells were 
present throughout a 1cm segment of spinal cord centered on the injury site (Fig 1F,G). Thus, 
new NG2 cells are continuously produced between 1d and 4wpi and these new cells are present 
throughout the rostal-caudal extent of the injured spinal cord for at least 7wpi.   
  
Although all spinal cords examined contained GFP+ NG2 cells, different distribution and 
numbers were observed based on time of virus injection. Most NG2 cells labeled at 1wpi 
accumulated 3 weeks later in a dense band along the lesion border/glial scar area, with fewer 
present in the spared white and gray matter around and distal to the lesion. A subset of GFP+ 
NG2s cells was also present within the lesion cavity. In tissue from later injections (e.g., virus at 
4wpi, perfused at 7wpi), the overall number of GFP+ cells was lower than the 1week injection 
group and the dense accumulation of new NG2 cells along the lesion border did not occur. 
Rather, at 7wpi, GFP+ NG2 cells were primarily located near the border of lesions and distal 
spared white matter (Fig 1C, G). In summary, NG2 cells divide for at least 4wpi, the progeny of 
which survive and distribute throughout the injured and spared tissue surrounding the lesion after 
SCI. In addition, cells dividing more acutely appear to contribute to the formation of the glial 
scar.   
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To verify using a different technique that NG2 cells divide for 4wpi, tissue sections from each 
cohort were double-labeled for NG2 and Ki-67 and used to quantify NG2 cell proliferation at 1w, 
2w, 3w, 4w, 6w and 10wpi. The number of NG2/Ki-67+ cells/mm2 was significantly increased at 
the epicenter and ~1mm rostral and caudal to epicenter for 4wpi (Fig 2A-C). The number of 
double-labeled cells declined thereafter but still remained 3- to 9-fold above naïve levels at 10 
weeks post-injury. Thus, these data verify that NG2 cells were dividing at each time of virus 
injection.   
  
New OLs arise from cells dividing from 1d – 4 weeks post-injury in rats  
While it is established that new OLs are generated 1-2 wpi, it is not known if more chronic lesion 
environments support OL differentiation. To compare oligodendrocyte genesis over time after 
SCI, tissue sections from rats injected with virus at 1dpi – 4wpi were examined for GFP+ OLs 3-
4 weeks later. At every time point examined (4 to 7wpi), new OLs (GFP/CC1+ cells) were 
present in spared tissue surrounding the lesion (Fig 3B-D), indicating that cells dividing between 
1d – 28dpi continuously differentiate into new OLs that remain for at least 7wpi  
  
The distribution of new OLs was similar to that of GFP/NG2+ cells. That is, at 4wpi GFP/CC1+ 
cells were present along the lesion border as well as concentrated in the spared tissue around the 
lesion, which matches where GFP+ NG2 cells were located. At 7wpi, GFP+ OLs were more 
diffusely distributed; the majority of GFP/CC1+ cells were in distal spared tissue close to the 
meningeal border of the white matter.  These results reveal that oligodendrogenesis occurs as late 
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at 4-7 weeks post-injury and that the pattern of NG2 cell proliferation predicts that of new OL 
generation.   
  
Oligodendrogenesis continues for at least 80 days after SCI in mice  
Since the SCI lesion pathology differs between rats and mice, two different reporter mouse lines 
were used to examine OL genesis after SCI in mice. Multiple cell types can express NG2, 
including pericytes and macrophages; therefore, reporter mice expressing GFP under the 
PDGFαR promoter were used, as this receptor is expressed specifically by OPCs. PDGFαR-
CreER:mT/mG mice express membrane-bound GFP (mG) (Muzumdar et al., 2007) in PDGFαR+ 
cells after tamoxifen treatment, which allows fine cellular processes and newly formed myelin to 
be visualized (Kang et al., 2010; Powers et al., 2013) (Fig 4A). The second line, PDGFαR-
CreER-ROSA mice, express cytoplasmic GFP in PDGFαR+ cells upon Cre-recombination by 
tamoxifen. In both lines, GFP expression was induced in PDGFαR+ progenitors at different 
times post-injury and the fate of those cells examined 3 weeks later (Table 2).   
  
To confirm efficient labeling of NG2 cells in PDGFαR-CreER:mT/mG mice, cross-sections of 
naïve spinal cords were immunolabeled for NG2. In these sections ~90% of GFP+ cells 
expressed NG2 and were present throughout white matter (Fig 4B) and gray matter (Fig 4C). To 
examine progenitor cell distribution and fate at different times after SCI, cohorts of PDGFαR-
CreER:mT/mG mice were given a 4d regimen of tamoxifen starting at 1d, 2w, 3w, 4w, or 6w 
after SCI and sacrificed 3 weeks later (Table 2). A robust increase in the number of GFP+/NG2+ 
cells was present at every time examined (4w, 5w, 6w, 7w, and 9wpi) throughout the gray and 
white matter compared to naïve spinal cords. (Fig. 4D-F). A low power comparison between 
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naïve and 7wpi tissue illustrates the more robust GFP and NG2 expression in the injured tissue is 
maintained almost 2 months post-injury (Fig 4G-H). This demonstrates that expanded NG2 cell 
population is maintained long-term, as noted previously (McTigue et al., 2001; Rabchevsky et al 
2007).    
  
Generation of new OLs acutely after SCI has been detected in mice (Lytle & Wrathall, 2007). To 
determine if oligodendrogenesis continues chronically, sections from PDGFαR-CreER:mT/mG 
mice were examined for GFP+ OLs following tamoxifen administration as described above 
(Table 2). New OLs were generated during every time interval examined, including 1- 4w, 2 - 
5w, 3 - 6w, 4 - 7w, and 6 - 9wpi. Numerous GFP+ OLs cells were present in spared white matter 
and gray matter in spinal cords in which GFP was turned on during every interval (Fig 5A-D). 
This reveals that progenitor cells differentiated into new OLs as late at between 6-9wpi. In 
longitudinal sections, GFP+ oligodendrocyte processes ran parallel to axons in spared white 
matter, resembling myelin profiles (Fig 5D).   
  
To confirm the observation of chronic oligodendrogenesis in another mouse line and to examine 
a later time point after SCI, PDGFαR-CreER-ROSA mice were given tamoxifen 4w or 8wpi and 
sacrificed 4 weeks later (Table 2). In both groups, GFP+/CC1+ cells were prevalent throughout 
spared white and gray matter (Fig 5E,F), confirming that chronic oligodendrogenesis continues 
after mouse SCI and that OL progenitors as late as 8wpi differentiate into new OLs that survive 
for an additional month.   
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To quantify new OLs generated during the first, second and fourth weeks post-injury, tissue 
collected at 4, 5, and 7wpi from PDGFαR-CreER-ROSA mice was cut in cross-section and used 
to count new OLs at the epicenter and 0.15 and 0.45mm distal to the injury site. In uninjured 
spinal cords, only 1-2 GFP/CC1+ cells per section could be identified in naïve spinal cord tissue, 
which is consistent with a low rate of adult oligodendrogenesis in previous reports (Psachoulia et 
al., 2009). The number of new OLs were formed between 2-5wpi, with the fewest OLs at the 
epicenter (Fig 6A). The number of new OLs generated between 2-5wpi was significantly 
increased compared to naïve tissue, and to earlier and later tissue at rostral/caudal distances. 
When collapsed over distance, the number of new OLs formed between 2-5wpi was 120-fold 
greater than in uninjured spinal cords (Fig 6B). While the number of new OLs generated over 0-
4wpi and 4-7wpi was lower than during 2-5, there still was a >40-fold increase during these time 
frames compared to uninjured spinal cords (Fig 6B).   
  
New OL lineage cells ensheathe axons and demonstrate signs of functional remyelination as 
late as 7-9wpi   
Rats injected with a GFP-retrovirus at 1d or 4wpi were immunolabeled for GFP, neurofilament 
(NF) and/or MBP and sacrificed at 4 or 7wpi, respectively. At 4wpi, GFP+ processes were 
commonly seen wrapping NF+ axons, some of which penetrated through the edges of the lesion 
cavity (Fig 7A). Z-stack analysis confirmed the co-localization of GFP, NF, and MBP on axons 
around the lesion border, indicating that newly formed OLs actively remyelinated axons (Fig 7B-
C).   
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Similar observations were made in animals sacrificed at 7wpi. GFP+ processes co-localized with 
NF and MBP, indicating that OLs born from NG2 cells proliferating at 4 weeks post-injury were 
also able to myelinate axons (Fig 7D). Evidence of chronic remyelination in rats was bolstered 
by triple-labeling for GFP, NF, and the paranodal protein Caspr. Around the lesion border at 
7wpi, GFP+ processes that wrapped NF+ axons were abutted adjacent to Caspr+ paranodal 
junctions, which are indicative of functional Nodes of Ranvier (Fig 7E). The number of 
GFP/NF/MBP+ and GFP/NF/Caspr+ axons was likely underestimated in the 6- and 7wpi 
animals as the uptake and spread of the GFP-retrovirus seemed to be diminished due to the 
lesion/scar tissue present at the time of injection.  
 
PDGFαR-CreER:mT/mG mice revealed similar findings. In these mice, GFP+ processes of OL 
lineage cells co-localized with NF+ axons at all time points examined, specifically between 0-4 
(Fig 8A), 3-6 (B), 4-7 (C, D), and 6-9wpi (E, F). These examples of GFP/NF+ processes were 
most often found along the meningeal borders of distal spared white matter of the spinal cord in 
mice. Tissue from 9wpi was also triple-labeled for GFP, NF, and Caspr+ (Fig 8F). Similar to rat 
tissue, Caspr+ paranodal junctions were present along NF+ axons, adjacent to GFP+ processes 
enwrapping the axon. The spacing between Caspr+ junctions was abnormally short, a hallmark 
of remyelination. Taken together, these observations in mice and rats indicate that new OLs are 
formed as late as 8 weeks after SCI and are capable of functional remyelination in the 
chronically injured spinal cord. 
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CNTF, FGF-2, and pSTAT3 expression are increased chronically in astrocytes after SCI in 
mice and rats 
Previous work from our lab showed that CNTF and FGF-2 are increased for at least 28dpi along 
the gliogenic lesion border after SCI (Tripathi & McTigue, 2008). To extend these findings to 
more chronic time points, mouse tissue from 12wpi was first immunolabeled for CNTF and 
compared to naïve spinal cords. Minimal CNTF immunoreactivity was present in naïve mouse 
tissue in motor neurons and some white matter glial cells (Fig 9A). At 12wpi in mouse, CNTF 
labeling was much more robust, both in spared white matter (Fig 9B) and especially in the glial 
scar (Fig 9B’). The majority of CTNF was expressed by GFAP+ astrocytes (Fig 9B’ insert), but 
not in OLs or NG2 cells (not shown). 
 
Labeling of FGF-2 demonstrated a similar increase over time. In control rat tissue, there were a 
number of FGF-2+ cells primarily in the gray matter (Fig 9C). After injury, FGF-2 labeling 
increased and was present throughout the spared tissue around the lesion for at least 6wpi in rat 
(Fig 9D). FGF-2 did not colocalize with NG2 or CC1 at 5wpi (not shown), and was almost 
exclusively present in GFAP+ astrocytes (Fig 9D’ insert).   
  
Next, to get an indication of whether the CNTF pathway was active at 12wpi, pSTAT3 
expression, which is downstream of CNTF signaling, was also analyzed. Naive mouse tissue 
contained virtually no pSTAT3+ cells (Fig 9E). In contrast, at 12wpi in mouse, there was an 
abundance of pSTAT3 labeling, which was localized primarily in GFAP+ astrocytes (Fig 9F). 
pSTAT3+ cells were particularly concentrated around the lesion border, but did not colocalize 
with NG2 or CC1 at 5wpi (not shown). 
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The expression of several NG2 cell fate-associated genes is chronically altered after SCI 
cDNA gene expression of ID2, ID4, Hes5, BMP4, and BMP2 was analyzed by real time qPCR in 
epicenter SCI mouse tissue from 1d - 4wpi. ID2, ID4, and Hes5 are negative regulators of NG2 
cell differentiation (Kondo & Raff, 2000; Samanta & Kessler, 2004; Li & Richardson, 2009). 
Expression of ID2 was significantly increased at 4wpi compared to naïve, 1dpi, 3dpi, and 7dpi 
(Fig 10A), while that of ID4 was significantly increased at both 2wpi and 4wpi compared to 
naïve, 1dpi, 3dpi, and 1wpi time points (Fig 10B). Conversely, expression of Hes5 was 
significantly decreased at 1dpi, 3dpi, 1wpi, and 4wpi compared to naïve levels (Fig 10C). BMP4, 
which regulates the expression of ID2 and ID4 (Samanta & Kessler, 2004), was significantly 
increased at 2wpi compared to 1dpi and at 4wpi compared to naïve, 1dpi, and 3dpi (Fig 10D). 
Expression of BMP2 was only significantly increased at 1dpi compared to all other time points 
examined (Fig 10E).  
  
DISCUSSION  
Recently, many therapeutic strategies following SCI have focused on promoting remyelination 
and protecting OL lineage cells (Mekhail et al., 2012). This is understandable considering the 
importance of myelin for proper axonal signal conduction as well as that of newly generated OLs 
to provide such remyelination. Independent of myelination, OLs are critical for maintaining 
axonal integrity and survival, perhaps even providing metabolic support to axons (Griffiths et al., 
1998; Nave, 2010a; Nave 2010b; Lee et al., 2012). This emphasis on NG2 cell survival and their 
subsequent capacity for remyelination following SCI has been bolstered overtime by several 
NG2 cell-transplantation studies that have reported varying degrees of increased remyelination 
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and/or functional recovery (Keirstead et al., 2005; Karimi-Abdolrezaee et al., 2006; Cao et al., 
2010; Plemel et al., 2011; Sun et al., 2013). 
 
It is difficult, however, to anticipate the eventual outcomes of such interventions when little is 
actually known about the natural long-term fate of NG2 cells following SCI and how these cells 
behave in the chronic injury milieu. While it is known that NG2 cells spontaneously proliferate 
for at least 4wpi and that a significant increase in newly formed OLs can be observed by 2wpi 
(McTigue et al., 2001; Zai and Wrathall, 2005; Horky et al., 2006; Lytle et al., 2006; Tripathi 
and McTigue, 2007; Rabchevsky et al., 2007), a more comprehensive and detailed analysis of 
NG2 cell fate after these acute times points has not been previously conducted. Therefore, using 
Cre-Er technology and GFP-expressing retroviruses, we sought to track the long-term fate of 
NG2 cell after SCI to determine when different groups of NG2 cells proliferated, differentiated, 
and began to remyelinate. Due to the differences in lesion pathology between mice and rats after 
SCI, we also assessed chronic NG2 cell fate in both of these species, including comparisons 
between two different transgenic mouse lines. In this study we demonstrate the following 
conclusions: 1) NG2 cells surrounding the lesions proliferated significantly until 4wpi; 2) 
oligodendrogenesis occurred continuously for at least 56-80dpi (8-11.5wpi); 3) chronically 
formed OL lineage cells demonstrated signs of active and maintained remyelination; 4) pro-OL 
survival factors CNTF, FGF-2, and pSTAT3 were chronically upregulated around the lesion, 
primarily in astrocytes; and finally 5) genes associated with NG2 cell fate determination (BMP4, 
ID2, ID4, Hes5) were significantly altered long-term after SCI.   
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Chronic NG2 cell proliferation and oligodendrogenesis after SCI 
The current results in mouse and rat revealed the chronic behavior of NG2/PDGFαR cells out to 
11.5wpi. In PDGFαR-CreER:mT/mG mice, NG2 cells were labeled with GFP and tracked for 
three week periods during 0-4wpi, 2-5wpi, 3-6wpi, 4-7wpi, and 6-9wpi. During each of these 
times GFP+ cells were identified that either remained NG2+/PDGFRa+ during the entire period 
or become CC1+ OLs (Figs 4 & 5). Quantification from mice revealed that oligodendrogenesis 
was most robust between 2-5wpi, but oligodendrogenesis still occurred between the periods of 0-
4, 3-6, 4-7, and 6-9wpi as well. It is possible that many more NG2 cells differentiated into OLs 
in the first two weeks after SCI, but did not survive to the 4wpi time point. In fact, Horky et al. 
(2006) reported that most dividing progenitor cells die in the first 24hrs after SCI. We then 
extended this study in PDGFαR-CreER-ROSA mice where we followed GFP+ cells during the 
periods of 4-7.5 and 8-11.5wpi and observed many GFP+/NG2+ and GFP+/CC1+ cells side-by-
side throughout spared gray and white matter (Fig 5f-g). GFP-retrovirus studies in rat once again 
confirmed these observations (out to 7wpi) with the additional knowledge that any GFP+/NG2+ 
or GFP+/CC1+ cells seen had been actively proliferating at the time of viral injection (Fig 1 & 
3). Taken together these three animals models present convincing evidence that 
oligodendrogenesis is an ongoing and chronic phenomenon, continuing for much longer and to 
greater extents than previously known.  
 
Evidence for late-term remyelination after SCI  
In addition to observing chronic oligodendrogenesis out to 80dpi, we also found evidence of on-
going remyelination. In PDGFαR-CreER:mT/mG mice clear examples could be found where 
GFP+ processes wrapped and engaged NF+ axons at all time points examined (0-4wpi, 2-5wpi, 
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3-6dpi, 4-7wpi, and 6-9wpi) (Fig 7). These observations were again confirmed and extended in 
GFP-retrovirus tissue in rat where triple-labeling demonstrated co-localization of GFP, NF and 
MBP at 4 and 7wpi, even along the lesion cavity borders (Fig 6). We also found GFP+ processes 
that wrapped NF+ axons that ended in Caspr+ paranodal junctions, indicative of functional 
synapses (Fig 6e).  
 
Long-term changes in transcription and astrocyte-derived growth factors correlate with 
oligodendrogenesis 
Previous work from our lab showed that expression of CNTF, FGF-2, and pSTAT3 was elevated 
for at least 4wpi around the lesion border after SCI (Tripathi & McTigue, 2008). CNTF is an 
astrocyte-derived factor that is known to promote NG2 cell proliferation, differentiation, 
migration, and myelin formation, especially after injury, as well as protect OLs against TNFα 
toxicity (Barres et al., 1993, 1996; Mayer et al., 1994; Marmur et al., 1998; Talbott et al., 2007; 
Salehi et al, 2013; Vernerey et al., 2013). CNTF also initiates the phosphorylation of STAT3 and 
enhances the effects of FGF-2 which are important for oligodendrogenesis (Dell’Albani et al., 
1998; Baron et al., 2000; Yokogami et al., 2000). It has also been suggested that activation of the 
STAT3 pathway in astrocytes after brain injury in both humans and rodents may help to prevent 
impairment of oligodendrocyte maturation (Nobuta et al., 2012). Thus, we examined the 
expression of these factors in our chronically injured tissue. We found that that expression of 
CNTF was still increased until at least 11.5wpi in mice and that of FGF-2 and pSTAT3 until at 
least 6wpi in rat (Fig 9). These factors were found almost exclusively in astrocytes. The chronic 
presence of these pro-OL proteins may contribute to the late-term oligodendrogenesis seen after 
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SCI and indicate that the injury environment contains factors permissive to OL maturation and 
survival.  
 
qPCR was also performed on genes associated with NG2 cell fate determination (Fig 10). ID2, 
ID4, and Hes5 are known inhibitors of oligodendrogenesis (Kondo & Raff, 2000; Samanta & 
Kessler, 2004; Li & Richardson, 2009). ID2 and ID4 do so by directly inhibiting the expression 
of Olig1 and Olig2 (Gokhan et al., 2005; Chen et al., 2009) while Hes5 inhibits Sox21 
expression (Wen et al., 2009). While expression of ID2 and ID4 was only increased at 2 or 4wpi, 
expression of Hes5 remained chronically downregulated from 1dpi until at least 4wpi. Thus, 
increases in ID2 and ID4 expression at 4wpi may contribute to a reduction in the rate of 
oligodendrogenesis at more chronic time points, but consistently decreased expression of Hes5 
may still be favorable for continual NG2 cell differentiation. Expression of BMP4, which 
regulates that of ID2 and ID4, increased in a similar time-dependent manner as these two factors 
(Samanta & Kessler, 2004). In contrast, expression of BMP2 was only significantly elevated at 
1dpi. BMP2 and BMP4 are also considered to be inhibitors of oligodendrogenesis, and it has 
been shown that these factors can influence NG2 cells to take on an astrocytic fate, both in 
development and in the adult (See et al., 2004; Cheng et al., 2007; Porlan et al., 2013). 
Conversely, others have shown that injection of BMP4 into the injured spinal cord can reduce 
astrogliosis (Sellers et al., 2009). As the entire epicenter of the injured mouse cord was used for 
qPCR analysis, it is not possible to ascertain which cell types are expressing these transcription 
factors. However, it is interesting to note that holistic expression changes in ID2, ID4, Hes5, and 
BMP4 are only seen or are maintained at chronic time points after SCI. These long-term gene 
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changes contribute to the idea of a chronically dynamic environment after SCI with undergoes 
significant structural and cellular changes long after acute injury effects have subsided.  
 
Therapeutic implications of chronic oligodendrogenesis after SCI 
The work presented here demonstrates that the injured cord’s capacity for oligodendrogenesis 
and subsequent remyelination, in both rats and mice, is greater in duration than previously 
known. In light of the dynamic changes involving oligodendrogenesis and remyelination that are 
still present at 11.5wpi (some of which may just be beginning), the appropriate time frame for 
therapeutic interventions directed at OL lineage cells should be reconsidered. This knowledge 
may both extend the window of opportunity for remyelination-promoting therapies as well as 
caution against intervening too soon due to the long-term dynamic cell changes that continue to 
occur. For example, insight into the chronic injury milieu is crucial for predicting how strategies 
such as stem cell transplantation will fare long-term or whether therapeutically-induced 
regenerated axons will become myelinated. Further, if protracted OL generation is crucial for 
lesion stabilization and chronic axon function, it will be important to understand the dynamics of 
this response so that pharmaceutical-based strategies do not interfere with this endogenous 
reparative response. Lastly, knowing that progenitor cells are responsive to environmental cues 
that promote oligodendrogenesis may provide new targets for treatments aimed at enhancing 
myelination, either of spared axons or axons induced to regenerate. 
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FIGURES   
TABLE 1: List of all primary antibodies used in this study.  
  
 
TABLE 2: Animal number and time course information.  
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FIGURE 1: Intraspinal injection of GFP-retrovirus successfully labels proliferating NG2 cells 
after SCI in rat. A. Widespread GFP-expression in the spinal cord at 4wpi (virus at 1dpi). B. In 
naïve cord, intraspinal injection stimulates only a small amount of cellular proliferation (GFP+ 
cells) around the injection site which does not spread throughout the cord. Examples of 
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GFP+/NG2+ cells at 1wpi (C), 4wpi (D, E), and 7wpi (F, G) at various locations throughout the 
spinal cord. (D) is a close up of the white box in (A). Location within the spinal cord where 
images were taken is indicated by associated schematics. DAPI is labeled in blue. Scale bars = 
20µm (A); 150µm (B); 50µm (C); 1250µm (D, E); 50µm (F, G).  
 
 
 
FIGURE 2: Number of Ki-67+/NG2+ cells in the rat spinal cord rostral to the epicenter (A), at 
the epicenter (B), and caudal to the epicenter (C) until 70dpi. Significance is in comparison to 
naïve counts.  
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FIGURE 3: Chronic oligodendrogenesis from proliferating progenitors in the injured rat spinal 
cord. Examples of GFP+/CC1+ cells around the lesion area at 4wpi (A), 6wpi (B), and 7wpi (C). 
DAPI is labeled in blue. Scale bars = 50µm (A, B); 30µm (C). 
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FIGURE 4: PDGFαR-CreER:mT/mG reporter mice successfully label NG2 cells that can be 
followed for at least 3 weeks after recombination. A. Schematic of breeding paradigm to 
generate PDGFαR-CreER:mT/mG mice. PDGFαR-CreER mice were crossed with ROSA26-
mGFP (mT/mG) mice to generate mice that ubiquitously express membrane-targeted tandem 
dimer Tomato (mT). Upon recombination by oral administration of tamoxifen however, all cells 
expressing the PDGFαR promoter begin to express membrane-targeted GFP (mG). pCA = 
promotor with CMV enhancer; pA = polyadenylation sequences; arrows = direction of 
transcription. Examples of GFP+/NG2+ cells in naïve spinal cord white (B) and gray (C) matter. 
Examples of GFP+/NG2+ around the lesion area of injured spinal cord at 4wpi (D), 5wpi (E), 
Hayes	  Forum	  2014	  
	   30	  
and 7wpi (F). Low-power visual comparison of naïve (G) and injured spinal cord (7wpi) (H) 
labeled with GFP and NG2. Even at 7wpi, GFP/NG2 expression is still considerably increased in 
the injured tissue. The injured tissue in (H) is 250µm rostral from the epicenter with no apparent 
signs of lesion. DAPI is labeled in blue. Scale bars = 50µm (B, D, E); 100µm (C, G, H); 10µm 
(F). 
 
 
FIGURE 5: Chronic oligodendrogenesis occurs after SCI in mice until at least 12wpi. Examples 
of GFP+/CC1+ cells in PDGFαR-CreER:mT/mG mice at 4wpi (A), 6wpi (B), 7wpi (C), and 
9wpi (D). Examples of GFP+/NG2+ and GFP+/CC1+ cells in PDGFαR-ROSA mice at 7.5wpi 
[52dpi] (E) and 11.5wpi [80dpi] (F). DAPI is labeled in blue. Scale bars = 30µm (A, E, F); 
20µm (B, C); 50µm (D).  
 
Hayes	  Forum	  2014	  
	   31	  
 
 
FIGURE 6: A. Quantification of newly formed OLs after SCI in PDGFαR-CreER:mT/mG mice 
between the periods of 0-4wpi, 2-5wpi, and 4-7wpi at the epicenter and rostral and caudal to the 
lesion. The number of newly formed OLs (GFP/CC1/DAPI+ cells) between 2-5wpi was 
significantly greater than in naïve tissue at 0.15mm and 0.45mm rostral and caudal to the 
epicenter, as well as compared to 0-4wpi (at 0.45mm rostral and caudal and 0.15mm rostral to 
the epicenter) and 4-7wpi (0.45mm rostral to the epicenter only). The number of triple-labeled 
cells was always lowest at the epicenter. 
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FIGURE 7: Proliferating OL lineage cells engage axons and express markers of functional 
remyelination after SCI in rat. A. Spinal cord tissue at 4wpi (virus injected at 1dpi) labeled with 
GFP and NF. (A’) A GFP+ processes ensheathes a NF+ axons extending into the lesion cavity. 
At 4wpi, GFP+ processes wrap NF+ axons and also colocalize with MBP around the lesion 
border (B-C). These images (A-C) represent NG2 cells that were proliferating at 1dpi and then 
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matured into OLs within 4 weeks that express mature myelin proteins and contribute to 
remyelination. D. Spinal cord tissue at 7wpi (virus injected at 4wpi) that also demonstrate 
remyelination by colocalization of GFP+ processes with NF+ axons and MBP within the lesion 
cavity. E. A GFP+ process from an OL lineage cell in 7wpi rat tissue that wraps a NF+ axon and 
ends in two adjacent Caspr+ paranodal junctions. Scale bars = 50µm (A, C); 20µm (D, E). 
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FIGURE 8: OL lineage cells continually wrap Caspr+ axons from 0-9wpi in mouse SCI tissue. 
GFP+ processes colocalize with NF+ axons during the time periods of 0-4wpi (A), 3-6wpi (B), 
4-7wpi (C, D), and 6-9wpi (E). Examples in (B) and (D) clearly demonstrate the sheaths that 
GFP+ processes form around axons. The image in (B) also shows the adjacent OL lineage cell 
that gives rise to the GFP+ processes wrapping a NF+ axon. Examples of GFP/NF colocalization 
could be found in both spared white matter (C, D, E) as well as along lesion borders (A, B). F. 
GFP+ processes in 9wpi tissue wrap NF+ axons that express Caspr+ paranodal junctions. DAPI 
is labeled in blue except in (F). Scale bars = 10µm (A, C, E, F); 20µm (D); 30µm (B, E).  
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FIGURE 9: Chronic increases in CNTF, FGF-2, and pSTAT3 after SCI in mice and rats. A. 
Naïve PDGFαR-ROSA mice spinal cord tissue shows very little labeling of CNTF. B. At 11.5wpi, 
robust CNTF is still present in PDGFαR-ROSA mice. CNTF expression is primarily found on 
astrocytes, especially around the lesion border (B’). C. Expression of FGF-2 in naïve rat spinal 
cord is restricted to the gray matter. D. At 6wpi in rat, expression of FGF-2 is upregulated and 
spread more diffusely throughout spared gray and white matter as well as within the lesion cavity. 
Like CNTF, FGF-2 expression is primarily found on astrocytes, especially around the lesion 
border (D’). E. In naïve mouse spinal cord there is virtually no expression of pSTAT3. F. At 
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12wpi in mouse, pSTAT3 is still upregulated and found primarily within astrocytes (F’). DAPI is 
labeled in blue. Scale bars = 100µm (A, B, E, F, F’); 50µm (B’); 200µm (C, D, D’). 
 
 
 
Figure 10: NG2 cell fate genes are chronically modulated after SCI. Relative gene expression of 
ID2 (A), ID4 (B), Hes5 (C), BMP2 (D), and BMP4 (E). A. Expression of ID2 is significantly 
increased at 28dpi (*) compared to naïve levels. B. Expression of ID4 is significantly increased 
at both 14dpi (*) and 28dpi (***) compared to naïve levels. C. Expression of Hes5 is 
significantly decreased compared to naïve levels at 1dpi (*), 3dpi (***), 7dpi (**), and 28dpi (*). 
D. Expression of BMP2 is significantly increased compared to naïve levels at 1dpi (*). E. 
Expression of BMP4 is significantly increased at 14dpi (**) compared to naïve levels.  
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